Annual report pursuant to Section 13 and 15(d)

INVENTORY (Tables)

v3.21.1
INVENTORY (Tables)
12 Months Ended
Dec. 31, 2020
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORY

At December 31, 2020 and 2019, inventory was comprised of the following:

    2020     2019  
Plants   $ 3,352,425     $ 395,167  
Ingredients and other raw materials     176,338       225,620  
Work-in-process     468,377       80,476  
Finished goods     2,833,431       518,166  
Total inventory   $ 6,830,571     $ 1,219,429  

 

The anticipated year-over-year increase of inventory is based on the Company’s implementation of its aforementioned Consolidation Plan whereby it is transitioning from a management and advisory firm in the cannabis space, to a cannabis licensee and direct owner of cannabis cultivation, manufacturing, and dispensary operations.